RxDoctor Payments Data

Pouya Mohajer, MD

Interventional Cardiology · Mount Kisco, NYNPI 1871819599

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,571 of the $6,748 with a category attached, or 82.6%. 21 manufacturers reported payments, led by Boston Scientific at 28.8% of the total. That places this record below the midpoint for interventional cardiology clinicians in NY, where the typical reported total is $8,047.

$6,748in general payments, 2019–2025

Across 134 payments — averaging $50.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Shockwave Medical, Inc$1K
  • Penumbra, Inc.$882
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$314
  • Astellas Pharma US Inc$297
  • Philips North America LLC$275
  • plus $2K from 15 others

What the payments were for

  • Travel & lodging$78012%
  • Food & beverage$5,57183%
  • Education$3976%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,748 in reported general payments places this provider in the 45th percentile of 382 interventional cardiology providers in New York.

See all interventional cardiology providers in New York →

Medicare billing

Part B allowed, 2024
$108,218
Medicare patients
230
Services billed
1,187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rosuvastatin Calcium24$359
Metoprolol Succinate16$337
Levothyroxine Sodium12$220
Simvastatin12$130

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Mount Kisco

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →